FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384008071> ?p ?o ?g. }

• W4384008071 endingPage "792" @default.
• W4384008071 startingPage "786" @default.
• W4384008071 abstract "Targeted therapy yields superior outcomes relative to genotype-agnostic therapy for patients with epidermal growth factor receptor (EGFR)-mutant lung cancer. Workflows that facilitate timely detection of EGFR mutations and early dispensation of osimertinib can improve management of this disease.We developed an Integrated Radiology, Pathology, and Pharmacy Program to minimize delays in initiating osimertinib. The intervention consisted of parallel workflows coupling interventional radiology, surgical pathology, and analysis of nucleic acids from frozen tissue with early pharmacy engagement. We compared time to EGFR testing results and time to treatment for participating patients with those of historical cohorts.Between January 2020 and December 2021, 222 patients participated in the intervention. The median turnaround time from biopsy to EGFR results was 1 workday. Forty-nine (22%) tumors harbored EGFR exon 19 deletions or EGFR L858R. Thirty-one (63%) patients were prescribed osimertinib via the intervention. The median interval between osimertinib prescription and osimertinib dispensation was 3 days; dispensation occurred within 48 hours for 42% of patients. The median interval between biopsy and osimertinib dispensation was 5 days. Three patients received osimertinib within 24 hours of EGFR results. Compared with patients with EGFR-mutant non-small-cell lung cancer who were diagnosed through routine workflows, the intervention led to a significant reduction in median time between biopsy and EGFR results (1 v 7 days; P < .01) and median time to treatment initiation (5 v 23 days; P < .01).Combining radiology and pathology workflows with early parallel pharmacy engagement leads to a significant reduction in time to initiating osimertinib. Multidisciplinary integration programs are essential to maximize clinical utility of rapid testing." @default.
• W4384008071 created "2023-07-13" @default.
• W4384008071 creator A5006018613 @default.
• W4384008071 creator A5009318345 @default.
• W4384008071 creator A5016656332 @default.
• W4384008071 creator A5018026441 @default.
• W4384008071 creator A5018355127 @default.
• W4384008071 creator A5022271791 @default.
• W4384008071 creator A5033765545 @default.
• W4384008071 creator A5036144153 @default.
• W4384008071 creator A5036335426 @default.
• W4384008071 creator A5037214933 @default.
• W4384008071 creator A5052578824 @default.
• W4384008071 creator A5056275493 @default.
• W4384008071 creator A5058184568 @default.
• W4384008071 creator A5064382279 @default.
• W4384008071 creator A5067299042 @default.
• W4384008071 creator A5067755945 @default.
• W4384008071 creator A5068198114 @default.
• W4384008071 creator A5070257501 @default.
• W4384008071 creator A5072389805 @default.
• W4384008071 creator A5078592778 @default.
• W4384008071 creator A5078810229 @default.
• W4384008071 creator A5083860637 @default.
• W4384008071 date "2023-09-01" @default.
• W4384008071 modified "2023-10-18" @default.
• W4384008071 title "Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib" @default.
• W4384008071 cites W1990626198 @default.
• W4384008071 cites W2062291041 @default.
• W4384008071 cites W2624310346 @default.
• W4384008071 cites W2770828094 @default.
• W4384008071 cites W2884913712 @default.
• W4384008071 cites W2908892126 @default.
• W4384008071 cites W2990041408 @default.
• W4384008071 cites W3145227691 @default.
• W4384008071 cites W4205273584 @default.
• W4384008071 cites W4213232115 @default.
• W4384008071 cites W4221119291 @default.
• W4384008071 doi "https://doi.org/10.1200/op.23.00031" @default.
• W4384008071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37437226" @default.
• W4384008071 hasPublicationYear "2023" @default.
• W4384008071 type Work @default.
• W4384008071 citedByCount "0" @default.
• W4384008071 crossrefType "journal-article" @default.
• W4384008071 hasAuthorship W4384008071A5006018613 @default.
• W4384008071 hasAuthorship W4384008071A5009318345 @default.
• W4384008071 hasAuthorship W4384008071A5016656332 @default.
• W4384008071 hasAuthorship W4384008071A5018026441 @default.
• W4384008071 hasAuthorship W4384008071A5018355127 @default.
• W4384008071 hasAuthorship W4384008071A5022271791 @default.
• W4384008071 hasAuthorship W4384008071A5033765545 @default.
• W4384008071 hasAuthorship W4384008071A5036144153 @default.
• W4384008071 hasAuthorship W4384008071A5036335426 @default.
• W4384008071 hasAuthorship W4384008071A5037214933 @default.
• W4384008071 hasAuthorship W4384008071A5052578824 @default.
• W4384008071 hasAuthorship W4384008071A5056275493 @default.
• W4384008071 hasAuthorship W4384008071A5058184568 @default.
• W4384008071 hasAuthorship W4384008071A5064382279 @default.
• W4384008071 hasAuthorship W4384008071A5067299042 @default.
• W4384008071 hasAuthorship W4384008071A5067755945 @default.
• W4384008071 hasAuthorship W4384008071A5068198114 @default.
• W4384008071 hasAuthorship W4384008071A5070257501 @default.
• W4384008071 hasAuthorship W4384008071A5072389805 @default.
• W4384008071 hasAuthorship W4384008071A5078592778 @default.
• W4384008071 hasAuthorship W4384008071A5078810229 @default.
• W4384008071 hasAuthorship W4384008071A5083860637 @default.
• W4384008071 hasConcept C104863432 @default.
• W4384008071 hasConcept C121608353 @default.
• W4384008071 hasConcept C126322002 @default.
• W4384008071 hasConcept C126838900 @default.
• W4384008071 hasConcept C143998085 @default.
• W4384008071 hasConcept C2775934546 @default.
• W4384008071 hasConcept C2776256026 @default.
• W4384008071 hasConcept C2777626846 @default.
• W4384008071 hasConcept C2778087573 @default.
• W4384008071 hasConcept C2779438470 @default.
• W4384008071 hasConcept C512399662 @default.
• W4384008071 hasConcept C513090587 @default.
• W4384008071 hasConcept C71924100 @default.
• W4384008071 hasConceptScore W4384008071C104863432 @default.
• W4384008071 hasConceptScore W4384008071C121608353 @default.
• W4384008071 hasConceptScore W4384008071C126322002 @default.
• W4384008071 hasConceptScore W4384008071C126838900 @default.
• W4384008071 hasConceptScore W4384008071C143998085 @default.
• W4384008071 hasConceptScore W4384008071C2775934546 @default.
• W4384008071 hasConceptScore W4384008071C2776256026 @default.
• W4384008071 hasConceptScore W4384008071C2777626846 @default.
• W4384008071 hasConceptScore W4384008071C2778087573 @default.
• W4384008071 hasConceptScore W4384008071C2779438470 @default.
• W4384008071 hasConceptScore W4384008071C512399662 @default.
• W4384008071 hasConceptScore W4384008071C513090587 @default.
• W4384008071 hasConceptScore W4384008071C71924100 @default.
• W4384008071 hasIssue "9" @default.
• W4384008071 hasLocation W43840080711 @default.
• W4384008071 hasLocation W43840080712 @default.
• W4384008071 hasOpenAccess W4384008071 @default.
• W4384008071 hasPrimaryLocation W43840080711 @default.
• W4384008071 hasRelatedWork W2054822224 @default.

• next